TransMedics Group Inc vs Vanguard Total Stock Market Index Fund ETF — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Vanguard Total Stock Market Index Fund ETF trades at $369.5. The key difference: Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | VTI | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | — |
52-Week High | $150.42 | $374.36 |
52-Week Low | $61.99 | $305.74 |
Enterprise Value | $2.94B | — |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →